Retailers, the makers of foods marketed for weight loss, and other types of companies could see knock-on effects from the rise of diabetes and weight loss drugs like Ozempic.
read more
Source: NY Times
22:23, September 2, 2023
Vivienne Walt and Lauren Hirsch